These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6271798)

  • 41. Determination of a dantrolene metabolite, 5-(p-nitrophenyl)-2-furoic acid, in plasma and urine by high-performance liquid chromatography.
    Wuis EW; Janssen MG; Vree TB; van der Kleijn E
    J Chromatogr; 1990 Apr; 526(2):575-80. PubMed ID: 2361999
    [No Abstract]   [Full Text] [Related]  

  • 42. Determination of ximoprofen and its metabolites in human urine by high-performance liquid chromatography with ultraviolet absorbance detection.
    Morris GR; Walmsley LM; Brodie RR; Chasseaud LF
    J Chromatogr; 1990 Sep; 530(2):377-85. PubMed ID: 2079512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of ranitidine in preterm and term neonates with gastroesophageal reflux.
    Asseff IL; Gaucin GB; Olguín HJ; Nájera JA; López AT; Guillé GP; Torres FZ
    BMC Pediatr; 2016 Jul; 16():90. PubMed ID: 27412521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamics.
    Suttle AB; Songer SS; Dukes GE; Hak LJ; Koruda M; Fleishaker JC; Brouwer KL
    J Clin Psychopharmacol; 1992 Aug; 12(4):282-7. PubMed ID: 1527233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C; St-Laurent M; Michaud JT; LeBel M
    Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.
    Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V
    Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of in vivo and in vitro metabolites of furanodiene in rats by high performance liquid chromatography-electrospray ionization mass spectrometry and nuclear magnetic resonance spectra.
    Chen M; Lou Y; Wu Y; Meng Z; Li L; Yu L; Zeng S; Zhou H; Jiang H
    J Pharm Biomed Anal; 2013 Dec; 86():161-8. PubMed ID: 23998967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Renal elimination and metabolism of etofenamate in volunteers after administration of various doses].
    Dell HD; Beckermann B; Fiedler J; Kamp R
    Arzneimittelforschung; 1990 Mar; 40(3):311-6. PubMed ID: 2346542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics and metabolism of mitoxantrone in man.
    Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
    Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients.
    Roberts AP; Harrison C; Dixon GT; Curtis JR
    Postgrad Med J; 1983 Jan; 59(687):25-7. PubMed ID: 6135202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved high-performance liquid chromatographic assay for cimetidine using ranitidine as an internal standard.
    Fleitman J; Torosian G; Perrin JH
    J Chromatogr; 1982 Apr; 229(1):255-8. PubMed ID: 6282913
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Simultaneous determination of exogenous phosphocreatine and its metabolite creatine in rabbit plasma using ion-pair reversed-phase high performance liquid chromatography].
    Xi H; Han G; Lü L; Zhang D
    Se Pu; 2011 Oct; 29(10):1000-4. PubMed ID: 22268357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studies.
    Neubeck M; Becker C; Henke D; Rösch W; Spahn-Langguth H; Mutschler E
    Arzneimittelforschung; 1993 Sep; 43(9):953-7. PubMed ID: 8240457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ranitidine disposition in patients with renal impairment.
    Meffin PJ; Grgurinovich N; Brooks PM; Miners JO; Cochran M; Stranks G
    Br J Clin Pharmacol; 1983 Dec; 16(6):731-4. PubMed ID: 6318787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.